Duanmu Xiaoyi
Executive Director
Board of DirectorsThe business, the people and the ownership behind Camsing Hc.
Business overview
Camsing Healthcare distributes and retails health supplements and food products in Singapore. These activities form the group’s principal operating businesses.
Listed security
Board & management
Executive Director
Board of DirectorsIndependent Director
Board of DirectorsIndependent Director
Board of DirectorsIndependent Director
Board of DirectorsRoles listed in Annual Report 2026; current appointments are not independently verified.
Holdings
Direct interest 40,000,007 shares (28.57%); deemed interest nil (-)
Substantial shareholders; direct and deemed interestDirect interest 40,000,000 shares (28.57%); deemed interest nil (-)
Substantial shareholders; direct and deemed interestDirect interest 21,861,000 shares (15.62%); deemed interest nil (-)
Substantial shareholders; direct and deemed interestDirect interest 17,008,120 shares (12.15%); deemed interest nil (-)
Substantial shareholders; direct and deemed interestTotal interests include direct and deemed holdings and may overlap across holders. These percentages should not be added together.
Group structure
| Company | Market | Ownership interest |
|---|---|---|
| William Jacks & Company (Singapore) Private LimitedHeld by the Company; proportion (%) of ownership interest 2026 and 2025 | Dormant; Singapore; proportion of ownership interest 100% (2026), 100% (2025); held by the Company | |
| Nature’s Farm Pte. Ltd.Held by WJ Singapore; proportion (%) of ownership interest 2026 and 2025 | Trading in health foods and supplements; Singapore; proportion of ownership interest 100% (2026), 100% (2025); held by WJ Singapore | |
Ownership interests and geographic information follow the annual report. Comparative years and footnote markers retain the report’s notation.
Senior executives
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Lim Kok Meng | Company Secretary | PDF p. 82 |
Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.
Related parties, people & properties
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Interested Person Transactions | it does not have any Interested Person Transactions exceeding $100,000 in aggregate value in FY2026 | Group, FY2026 | PDF p. 29 |
| Compensation of key management personnel | 568 $'000 | Group, 2026 (comparative 2025: 660) | PDF p. 72 |
| Balances owing to I-Nitra | 139 $'000 | Group, as at 31 January 2026 (2025: 347) · As at 2026-01-31 | PDF p. 68 |
| Loans from major shareholders | In FY2026, the major shareholders extended loans of $800,000 (2025: $1,000,000) to the Group and the Company, which are unsecured and interest-free | Group and Company, FY2026 | PDF p. 68 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Undertaking from controlling shareholder | an undertaking from its controlling shareholder to provide the necessary financial support for the next twelve months | Group and Company | PDF p. 46 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Duanmu Xiaoyi | 264 S$'000 | FY2026, Executive Director; 100% salary | PDF p. 22 |
| Liu Xiaohua | 30 S$'000 | FY2026, Non-Executive and Independent Director; 100% directors' fees | PDF p. 22 |
| Tan Keng Keat | 55 S$'000 | FY2026, Non-Executive and Independent Director; 100% directors' fees | PDF p. 22 |
| Xue Congyan | 30 S$'000 | FY2026, Non-Executive and Independent Director; 100% directors' fees | PDF p. 22 |
| Directors’ fees | 115 $'000 | Group, FY2026 (2025: 115) | PDF p. 70 |
| S$250,000 and below | S$250,000 and below | FY2026, one key management personnel (Chong Wee Pang) | PDF p. 22 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Employee benefits expenses | 1,982 $'000 | Group, FY2026 (2025: 2,304) | PDF p. 71 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| Subsequent to the balance sheet date, share allotment | the Company allotted and issued 50 million new ordinary shares in the Company pursuant to the conversion of the convertible bonds amounting to $2.5 million on 8 May 2026 | Company · As at 2026-05-08 | PDF p. 65 |
| Subsequent to the balance sheet date, loans | unsecured and interest-free loans of $200,000 and $300,000 were received from the major shareholder in March and April 2026 | Group | PDF p. 68 |
| Item | Value | Period / scope | Source |
|---|---|---|---|
| OUTLOOK | the Group remains cautious amid continued macroeconomic uncertainties and evolving consumer spending patterns | Group | PDF p. 8 |
| OUTLOOK | The Group will continue to focus on strengthening its core brand of Nature’s Farm, enhancing customer engagement through digital channels, improving inventory management | Group | PDF p. 8 |
Extracted from Annual Report 2026 and checked against the cited pages; see the original report for full context.
Corporate information